Medication for obesity has advanced significantly in recent years. In this episode, we cover the key principles of pharmacotherapy, its possibilities and limitations. You will learn why medication is not a miracle cure but can serve as important support for individualized lifestyle changes. We present the core pillars of pharmacotherapy and review different weight-loss medication options:
Mysimba (naltrexone/bupropion): An oral combination medication that affects the brain’s reward system and curbs appetite.
Saxenda (liraglutide): An injectable GLP-1 analogue that increases feelings of fullness.
Wegovy (semaglutide): An injectable GLP-1 analogue that regulates appetite and increases satiety.
Mounjaro (tirzepatide): The newest injectable GLP-1/GIP analogue, which affects appetite and blood glucose control.
Qsymia (phentermine/topiramate): A capsule-based combination medication that influences both appetite and metabolism.
Orlistat: Prevents the absorption of fats from food. Also available without a prescription.









